Search
for

    Sort by

    Research 91–120 of 1000+

    1. Managing the adverse effects of cytotoxic chemotherapy at the level of primary healthcare 2023 · 1 citations
    2. Research Advances in Therapeutic Strategies and Drug Delivery Systems for Pathological Scars Pharmaceutics · 2026
    3. Bladder Cancer Survival of Men Receiving 5α-Reductase Inhibitors The Journal of Urology · 2018 · 20 citations
    4. Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis The Journal of Dermatology · 2024 · 7 citations
    5. Janus Kinase inhibitors in dermatology: a review Portuguese Journal of Dermatology and Venereology · 2023 · 1 citations
    6. Risk of rhabdomyolysis from 5-α reductase inhibitors Pharmacoepidemiology and Drug Safety · 2018 · 6 citations
    7. Bladder cancer survival in men using 5-alpha-reductase inhibitors European Urology Supplements · 2018 · 3 citations
    8. Association of long-term 5α-reductase inhibitor use with survival in men with renal cell carcinoma: a nationwide population-based cohort study Frontiers in Pharmacology · 2026
    9. Procyanidin B-2, extracted from apples, promotes hair growth: a laboratory study 2002 · 37 citations
    10. Janus kinase inhibitors for alopecia areata: a review of clinical data Frontiers in Immunology · 2025 · 4 citations
    11. CXCR3 Blockade Inhibits T Cell Migration into the Skin and Prevents Development of Alopecia Areata Journal of Immunology · 2016 · 64 citations
    12. Dual inhibitors of urease and carbonic anhydrase-II from <i>Iris</i> species Pure and Applied Chemistry · 2019 · 8 citations
    13. Purple corn extract improves benign prostatic hyperplasia by inhibiting 5 alpha-reductase type 2 and inflammation in testosterone propionate-induced rats Frontiers in Pharmacology · 2025 · 2 citations
    14. Effects of 5-alpha reductase inhibitors Current Opinion in Urology · 2018 · 2 citations
    15. Association Between 5α-Reductase Inhibitors and Prostate Cancer Mortality The International Journal of Medical Science and Health Research · 2024 · 1 citations
    16. The antimycotic agent clotrimazole inhibits melanogenesis by accelerating ERK and PI3K-/Akt-mediated tyrosinase degradation Experimental Dermatology · 2015 · 15 citations
    17. Ageratum Conyzoides L. Extract Inhibits 5α-Reductase Gene Expression and Prostaglandin D2 Release in Human Hair Dermal Papilla Cells and Improves Symptoms of Hair Loss in Otherwise Healthy Males and Females in an Open Label Pilot Study Journal of cosmetology & trichology · 2021
    18. In silico prediction of prostaglandin D2 synthase inhibitors from herbal constituents for the treatment of hair loss Journal of Ethnopharmacology · 2015 · 30 citations
    19. Purified Vitexin Compound 1 Inhibits UVA-Induced Cellular Senescence in Human Dermal Fibroblasts by Binding Mitogen-Activated Protein Kinase 1 Frontiers in Cell and Developmental Biology · 2020 · 3 citations
    20. Novel type 1 5a-reductase Inhibitors with Antiproliferative Potential on LNCaP cells 2023
    21. Blockade of S100A3 activity inhibits murine hair growth Genetics and Molecular Research · 2015 · 1 citations
    22. Androgens in SARS-CoV-2 Coronavirus Infections Physiological Research · 2021 · 5 citations
    23. Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers 2021 · 36 citations
    24. General Dermatology Springer eBooks · 2017
    25. Roles of tumor suppressors in regulating tumor-associated inflammation Cell Death & Differentiation · 2014 · 44 citations
    26. Cardiodermatology: the heart of the connection between the skin and cardiovascular disease Nature Reviews Cardiology · 2024 · 10 citations
    27. Pegylated-interferon-α<sub>2a</sub>in clinical practice: how to manage patients suffering from side effects Expert Opinion on Drug Safety · 2011 · 17 citations
    28. The Current Status of the Pharmaceutical Potential of Juniperus L. Metabolites Medicines · 2018 · 19 citations
    29. Targets to treat androgen excess in polycystic ovary syndrome Expert Opinion on Therapeutic Targets · 2015 · 14 citations
    30. Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development Clinical Pharmacokinetics · 2023 · 6 citations